Heartflow, Inc. (HTFL) insider trading

By person

11 insiders · 54 transactions

27.3×

John C.M. Farquhar holds 27.3 times base salary in stock. $17.71M of shares against $647.97K in salary for 2025.

Salary from the company's own proxy. The shares are what John C.M. Farquhar last reported holding, valued at $55.01, the price Common Stock was last bought or sold at on the open market here, on 22 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bain Capital Life Sciences Investors, LLC entity

10% owner

—

$115.00M (5)

−$115.00M

8,448,158

9.72%

$464.73M

—

John C.M. Farquhar

Chief Executive Officer

—

$12.87M (15) scheduled

−$12.87M

283,014

0.3255%

$15.57M

−24.2%

Campbell Rogers

Chief Medical Officer

—

$8.03M (8) scheduled

−$8.03M

218,993

0.2519%

$12.05M

+50.5%

Vikram Verghese

Chief Financial Officer

—

$4.98M (8) scheduled

−$4.98M

155,183

0.1785%

$8.54M

+35.2%

Jeffrey C Lightcap

Director

$1.05M (1)

—

+$1.05M

4,909,223

5.65%

$270.06M

—

Julie A Cullivan

Director

—

$446.61K (2) scheduled

−$446.61K

27,291

0.0314%

$1.50M

−38.6%

William C Weldon

Director

—

243,931

0.2805%

$13.42M

+333.5%

Timothy C Barabe

Director

—

188,231

0.2165%

$10.35M

+411.8%

Casey M Tansey

Director

—

114,750

0.1320%

$6.31M

—

Marie L. Jones

Chief Accounting Officer

—

32,176

0.0370%

$1.77M

—

HealthCor Partners Management LP entity

Director

—

0.0000%

$0.00

—

Heartflow, Inc.

What the insiders did Net selling

By person